Researchers at the University of Geneva, together with colleagues in Switzerland, France, the United States and Israel, ...

In today’s ACT Brief, we break down FDA’s new superiority requirement reshaping CAR-T development, examine Pfizer’s global move into oral small-molecule GLP-1 therapy, and highlight new MONALEESA ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space. Clinical trials are possibly the most vital access of the drug development process, and ...

Please provide your email address to receive an email when new articles are posted on . A comprehensive behavior change intervention aimed at increasing physical activity yielded improvements in ...

To inform continued development of the novel immune agent GEN-1, we compared ovarian cancer patients' end points from a neoadjuvant single-arm phase IB study with those of similar historic clinical ...

Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

Over the past few years, we’ve seen a wave of digital innovation in clinical trials: decentralized models, eConsent, real-time monitoring and direct-to-patient logistics. We’ve digitized nearly every ...

—Using a systematic review of current literature, the World Allergy Organization proposed definitions in CSU for remission and cure and also proposed criteria for therapy step-down. “The step-by-step ...

Researchers are using analytics and existing patient data to ease recruitment, reduce costs, and accelerate timelines. In association withMedidata Clinical trials have never been more in the public ...

Background Clinical assessments and rehabilitation in athletic groin pain (AGP) have focused on specific anatomical structures and uniplanar impairments rather than whole body movement. Objective To ...